Article
The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer.
Cancer chemotherapy and pharmacology - 1 Feb 2023
Hjorth Cathrine F, Damkier Per, Stage Tore B, Feddersen Søren, Hamilton-Dutoit Stephen, Ejlertsen Bent, Lash Timothy L, Bøggild Henrik, Sørensen Henrik T, Cronin-Fenton Deirdre
Abstract excerpt
PURPOSE: Breast cancer treatment is associated with adverse effects, which may delay return-to-work. Single nucleotide polymorphisms (SNPs) may influence the risk and severity of treatment toxicities, which in turn could delay return-to-work. We examined the association of 26 SNPs with return-to-work in premenopausal women with breast cancer. METHODS: Using Danish registries, we identified premenopausal women...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.